Chemoinformaics analysis of GAMMA-GLUTAMYL-S-ALLYLCYSTEINE
Molecular Weight | 290.341 | nRot | 10 |
Heavy Atom Molecular Weight | 272.197 | nRig | 4 |
Exact Molecular Weight | 290.094 | nRing | 0 |
Solubility: LogS | -1.757 | nHRing | 0 |
Solubility: LogP | -2.625 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 39.4823 |
nHD | 4 | BPOL | 23.1217 |
QED | 0.32 |
Synth | 3.252 |
Natural Product Likeliness | 0.571 |
NR-PPAR-gamma | 0.117 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.026 |
HIA | 0.022 |
CACO-2 | -6.302 |
MDCK | 0.00000358 |
BBB | 0.241 |
PPB | 0.271266 |
VDSS | 0.329 |
FU | 0.602239 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.023 |
CYP2c19-inh | 0.04 |
CYP2c19-sub | 0.038 |
CYP2c9-inh | 0.205 |
CYP2c9-sub | 0.553 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.147 |
CYP3a4-inh | 0.018 |
CYP3a4-sub | 0.005 |
CL | 2.772 |
T12 | 0.833 |
hERG | 0.011 |
Ames | 0.015 |
ROA | 0.019 |
SkinSen | 0.119 |
Carcinogencity | 0.053 |
EI | 0.051 |
Respiratory | 0.148 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.591668 |